» Articles » PMID: 26893849

Development of Combined Thymic Carcinoma and Thymoma in an Extrathymic Lesion During Long Follow-up for Recurrent Thymoma

Overview
Journal Mol Clin Oncol
Specialty Oncology
Date 2016 Feb 20
PMID 26893849
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The present study reported a rare case of combined thymic squamous cell carcinoma and thymoma exhibiting a mass on the left chest wall. The patient underwent thoracotomy for invasive thymoma 15 years previously, however, suffered a relapse in the left intrathoracic space. Radiotherapy, chemotherapy and partial resection, as secondary surgery for the intrathoracic mass, were performed. The histological findings in the resected specimens revealed type B3 thymoma. As the patient developed a left chest wall mass and pain in 2013, the mass was resected. The histological findings indicated two separate components composed of type B3 thymoma and squamous cell carcinoma. Immunohistological findings revealed that the thymoma cells were positive for CD5, while the thymic carcinoma cells were negative for CD5. Several reports have demonstrated the coexistence of thymic carcinoma and thymoma in the primary thymus, however, the development of a combined tumor in an extrathymic lesion is extremely rare. The present case had a long follow-up for recurrent thymoma. The present case indicated that the development and/or coexistence of malignant components in the thymoma must be taken into consideration for the treatment and/or management of patients with thymoma and that a pre-existence of CD5 expression in thymoma and the lost change may be associated with the process of malignant transformation.

Citing Articles

Genomic insights into molecular profiling of thymic carcinoma: a narrative review.

Takata S Mediastinum. 2024; 8:39.

PMID: 39161584 PMC: 11330910. DOI: 10.21037/med-24-5.


Thymoma and Synchronous Primary Mediastinal Seminomas with Florid Follicular Lymphoid Hyperplasia in the Anterior Mediastinum: A Case Report and Review of the Literature.

Lee H, Jang I, Jeon K, Ko G, Lee J, Kim D J Pathol Transl Med. 2017; 51(2):165-170.

PMID: 28147469 PMC: 5357752. DOI: 10.4132/jptm.2016.08.24.

References
1.
Dorfman D, Shahsafaei A, Chan J . Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol. 1997; 21(8):936-40. DOI: 10.1097/00000478-199708000-00008. View

2.
Suster S, Moran C . Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol. 1996; 20(12):1469-80. DOI: 10.1097/00000478-199612000-00006. View

3.
Morinaga S, Sato Y, Shimosato Y, Sinkai T, Tsuchiya R . Multiple thymic squamous cell carcinomas associated with mixed type thymoma. Am J Surg Pathol. 1987; 11(12):982-8. DOI: 10.1097/00000478-198712000-00009. View

4.
Suarez Vilela D, Salas Valien J, Gonzalez Moran M, Izquierdo Garcia F, Riera Velasco J . Thymic carcinosarcoma associated with a spindle cell thymoma: an immunohistochemical study. Histopathology. 1992; 21(3):263-8. DOI: 10.1111/j.1365-2559.1992.tb00385.x. View

5.
Gadalla S, Rajan A, Pfeiffer R, Kristinsson S, Bjorkholm M, Landgren O . A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer. 2010; 128(11):2688-94. PMC: 2992797. DOI: 10.1002/ijc.25583. View